Annual Total Liabilities
$50.53 M
-$6.85 M-11.94%
December 31, 2023
Summary
- As of February 8, 2025, LVTX annual total liabilities is $50.53 million, with the most recent change of -$6.85 million (-11.94%) on December 31, 2023.
- During the last 3 years, LVTX annual total liabilities has risen by +$37.67 million (+292.79%).
- LVTX annual total liabilities is now -11.94% below its all-time high of $57.38 million, reached on December 31, 2022.
Performance
LVTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$50.36 M
+$958.00 K+1.94%
September 30, 2024
Summary
- As of February 8, 2025, LVTX quarterly total liabilities is $50.36 million, with the most recent change of +$958.00 thousand (+1.94%) on September 30, 2024.
- Over the past year, LVTX quarterly total liabilities has dropped by -$6.06 million (-10.74%).
- LVTX quarterly total liabilities is now -16.07% below its all-time high of $60.01 million, reached on March 31, 2023.
Performance
LVTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
LVTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.9% | -10.7% |
| 3 y3 years | +292.8% | -10.7% |
| 5 y5 years | +1611.2% | -10.7% |
LVTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.9% | +142.0% | -16.1% | +141.2% |
| 5 y | 5-year | -11.9% | +1611.2% | -16.1% | +291.5% |
| alltime | all time | -11.9% | +1611.2% | -16.1% | +291.5% |
LAVA Therapeutics NV Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $50.36 M(+1.9%) |
| Jun 2024 | - | $49.41 M(+2.0%) |
| Mar 2024 | - | $48.41 M(-4.2%) |
| Dec 2023 | $50.53 M(-11.9%) | $50.53 M(-10.4%) |
| Sep 2023 | - | $56.42 M(-3.8%) |
| Jun 2023 | - | $58.65 M(-2.3%) |
| Mar 2023 | - | $60.01 M(+4.6%) |
| Dec 2022 | $57.38 M | $57.38 M(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $57.23 M(+169.1%) |
| Jun 2022 | - | $21.27 M(+0.8%) |
| Mar 2022 | - | $21.10 M(+1.0%) |
| Dec 2021 | $20.88 M(+62.3%) | $20.88 M(-7.4%) |
| Sep 2021 | - | $22.54 M(-2.1%) |
| Jun 2021 | - | $23.02 M(-18.7%) |
| Mar 2021 | - | $28.32 M(+120.2%) |
| Dec 2020 | $12.87 M(+335.7%) | $12.87 M |
| Dec 2019 | $2.95 M | - |
FAQ
- What is LAVA Therapeutics NV annual total liabilities?
- What is the all time high annual total liabilities for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV annual total liabilities year-on-year change?
- What is LAVA Therapeutics NV quarterly total liabilities?
- What is the all time high quarterly total liabilities for LAVA Therapeutics NV?
- What is LAVA Therapeutics NV quarterly total liabilities year-on-year change?
What is LAVA Therapeutics NV annual total liabilities?
The current annual total liabilities of LVTX is $50.53 M
What is the all time high annual total liabilities for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high annual total liabilities is $57.38 M
What is LAVA Therapeutics NV annual total liabilities year-on-year change?
Over the past year, LVTX annual total liabilities has changed by -$6.85 M (-11.94%)
What is LAVA Therapeutics NV quarterly total liabilities?
The current quarterly total liabilities of LVTX is $50.36 M
What is the all time high quarterly total liabilities for LAVA Therapeutics NV?
LAVA Therapeutics NV all-time high quarterly total liabilities is $60.01 M
What is LAVA Therapeutics NV quarterly total liabilities year-on-year change?
Over the past year, LVTX quarterly total liabilities has changed by -$6.06 M (-10.74%)